2 results match your criteria: "Dansk Multipel Sklerose Center[Affiliation]"
[Fampridine and multiple sclerosis].
Ugeskr Laeger
January 2014
Neurologisk Klinik, Dansk Multipel Sklerose Center, Rigshospitalet, Blegdamsvej 9, 2100 København Ø.
The background for the use of fampridine, the indications, contraindications, side effects, and recommendations for Danish patients with multiple sclerosis are reviewed.
View Article and Find Full Text PDF[Natalizumab (Tysabri)].
Ugeskr Laeger
September 2007
Rigshospitalet, Neurocentret, Dansk Multipel Sklerose Center, København Ø.
Natalizumab is a humanized recombinant monoclonal antibody against alpha4-intigrin. In a large phase III study on relapsing-remitting MS Natalizumab reduced the relapse rate by 68% and the appearance of permanent neurological deficits by 42%. Currently, Natalizumab is the most effective disease-modifying treatment of relapsing-remitting MS.
View Article and Find Full Text PDF